AstraZeneca Pharma India Ltd. — AGM Information 2024

Aug 8, 2024

==> picture [462 x 47] intentionally omitted <==

August 8, 2024

The Manager- Listing BSE Limited Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai - 400001

National Stock Exchange of India Limited

Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra –Kurla Complex, Bandra (E), Mumbai - 400051

Dear Sir,

Sub: Summary of Proceedings of 45[th] Annual General Meeting – Ref: Scrip code BSE: 506820, NSE: ASTRAZEN

Pursuant to the provisions of Regulation 30 read with Part A of Schedule III to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the following business were transacted at the 45[th] Annual General Meeting (AGM) of the Company held on August 8, 2024 at 3.00 P.M. through Video Conferencing/Other Audio Visual Means and concluded at 5:15 P.M.:

1. Adoption of Financial Statements for the financial year ended March 31, 2024 and the Reports of the Board of Directors and Auditors thereon.

2. Declaration of dividend of Rs. 24/- per Equity Share.

3. Appointment of Dr. Sanjeev Kumar Panchal (DIN: 09823879) who retires by rotation, and being eligible, offers himself for re-appointment.

4. Ratification of Cost Auditor’s remuneration.

Kindly note that voting results will be announced upon the receipt of Scrutinizer’s Report and will be submitted as per Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Please take same on record.

Thanking you,

For AstraZeneca Pharma India Limited

MANASA Digitally signed by MANASA RAMA RAMA Date: 2024.08.08 18:39:37 +05'30'

Manasa. R

Company Secretary

==> picture [452 x 64] intentionally omitted <==